The higher DNMT3a expression in liver cancer cells compared to normal liver cells (Fig. 5g) suggests that downregulation of miR-502-5p in HCC may otherwise facilitate DNMT3a expression. The gene discussed is DNMT3A; the disease is hepatocellular carcinoma.